OpenURL Connection Search

Select item for more details and to access through your institution.

Significant CT dose reduction of 2-[18F]FDG PET/CT in pretreatment pediatric lymphoma without compromising the diagnostic and staging efficacy.
Published in:
European Radiology, 2023, v. 33, n. 3, p. 2248, doi. 10.1007/s00330-022-09145-z
By:
- Tang, Si;
- Hu, Yingying;
- Zeng, Jiling;
- Li, Zhijian;
- Jiang, Yongluo;
- Li, Yinghe;
- Wang, Jingyi;
- Sun, Hongyan;
- Wu, Xiao;
- Zhou, Yun;
- Zhang, Xu;
- Zhao, Yumo
Publication type:
Article
Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity scorematched cohorts of cancer of unknown primary treatment.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1191611
By:
- Youlong Wang;
- Qi Huang;
- Guanqing Zhong;
- Jun Lv;
- Qinzhi Guo;
- Yifei Ma;
- Xinjia Wang;
- Jiling Zeng
Publication type:
Article
Prognostic value of liver biochemical parameters for COVID-19 mortality.
Published in:
Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2021, v. 21, p. 1, doi. 10.1016/j.aohep.2020.10.007
By:
- Lin Ye;
- Bin Chen;
- Yitong Wang;
- Yi Yang;
- Jiling Zeng;
- Guangtong Deng;
- Yuhao Deng;
- Furong Zeng
Publication type:
Article
Cerebral 18F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267025
By:
- Yifei Ma;
- Jiling Zeng;
- Fadian Ding;
- Yiwei Xu;
- Youlong Wang;
- Guanqing Zhong;
- Nianqi Liu;
- Yanqi Wang;
- Yiming Li;
- Shuqin Chen;
- Xiaolong Wei;
- Pengfei Zhu;
- Guangmin Jian;
- Yu Si Niu;
- Guangzhen Fu;
- Cantong Liu;
- Guiqiang Li;
- Xiaotong Zhou;
- Ao Zhang;
- Shangeng Weng
Publication type:
Article
Cerebral 18F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1129, doi. 10.2967/jnumed.123.267025
By:
- Yifei Ma;
- Jiling Zeng;
- Fadian Ding;
- Yiwei Xu;
- Youlong Wang;
- Guanqing Zhong;
- Nianqi Liu;
- Yanqi Wang;
- Yiming Li;
- Shuqin Chen;
- Xiaolong Wei;
- Pengfei Zhu;
- Guangmin Jian;
- Yu Si Niu;
- Guangzhen Fu;
- Cantong Liu;
- Guiqiang Li;
- Xiaotong Zhou;
- Ao Zhang;
- Shangeng Weng
Publication type:
Article
Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, p. 54S, doi. 10.2967/jnumed.123.266948
By:
- Wanqi Chen;
- Yinghe Li;
- Zhijian Li;
- Yongluo Jiang;
- Yingpu Cui;
- Jiling Zeng;
- Yiwen Mo;
- Si Tang;
- Shatong Li;
- Lei Liu;
- Yumo Zhao;
- Yingying Hu;
- Wei Fan
Publication type:
Article
Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis.
Published in:
International Journal of Biological Markers, 2019, v. 34, n. 3, p. 213, doi. 10.1177/1724600819874487
By:
- Zeng, Furong;
- Chen, Bin;
- Zeng, Jiling;
- Wang, Zhiming;
- Xiao, Liang;
- Deng, Guangtong
Publication type:
Article
Can we predict the severity of coronavirus disease 2019 with a routine blood test?
Published in:
Polish Archives of Internal Medicine, 2020, v. 130, n. 5, p. 400, doi. 10.20452/pamw.15331
By:
- Furong Zeng;
- Linfeng Li;
- Jiling Zeng;
- Yuhao Deng;
- Huining Huang;
- Bin Chen;
- Guangtong Deng
Publication type:
Article

Found: 8

Significant CT dose reduction of 2-[<sup>18</sup>F]FDG PET/CT in pretreatment pediatric lymphoma without compromising the diagnostic and staging efficacy.

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity scorematched cohorts of cancer of unknown primary treatment.

Prognostic value of liver biochemical parameters for COVID-19 mortality.

Cerebral <sup>18</sup>F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment.

Cerebral <sup>18</sup>F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment.

Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center.

Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis.

Can we predict the severity of coronavirus disease 2019 with a routine blood test?